KayfabeWire
Story Hub1 update1 source

Ex-WWE Champ Returns on RAW After Long Speculation, Changes MITB Qualifier Outcome

Live coverage and related reports for Ex-WWE Champ Returns on RAW After Long Speculation, Changes MITB Qualifier Outcome.

AI Story Summary

What happened?

Bayley returned to WWE RAW on Sept. 7 after being off television for months amid speculation about her status. According to the report, she immediately got involved in a Money in the Bank qualifying match featuring Lyra Valkyria, Sol Ruca, and Maxxine Dupri, changing the match outcome.

Key Takeaways

  • Bayley is back on WWE RAW after months away from television.
  • Her return followed a period of speculation about her future with WWE.
  • She got involved in a Money in the Bank qualifying match on the Sept. 7 episode.
  • The qualifier involved Lyra Valkyria, Sol Ruca, and Maxxine Dupri.
  • The report says Bayley’s involvement changed the match outcome.

AI Timeline

Months prior

Bayley was absent from WWE television, leading to uncertainty and speculation about her status.

Sept. 7 RAW

A Money in the Bank qualifying match took place involving Lyra Valkyria, Sol Ruca, and Maxxine Dupri.

Bayley returns

Bayley appeared on RAW, marking her return after months away.

Qualifier impacted

Bayley inserted herself into the match and changed the outcome, according to the report.

Model: gpt-5.5Generated: Sep 8, 2:04 AM

Sources Covering This Story

WrestleZone

Timeline

Sep 8, 1:49 AM

Ex-WWE Champ Returns on RAW After Long Speculation, Changes MITB Qualifier Outcome

WrestleZone • WWE

Bayley returned to WWE RAW on Sept. 7 after months away from television, ending a period of uncertainty surrounding her future with the company. The former Women’s Champion didn’t simply return — she immediately inserted herself into a Money in the Bank qualifying match involving Lyra Valkyria, Sol Ruca, and Maxxine Dupri. Bayley had been […] The post Ex-WWE Champ Returns on RAW After Long Speculation, Changes MITB Qualifier Outcome appeared first on Wrestlezone.